164 related articles for article (PubMed ID: 28413414)
21. Acetylcholinesterase inhibitors in Alzheimer's disease influence Zinc and Copper homeostasis.
Giacconi R; Giuli C; Casoli T; Balietti M; Costarelli L; Provinciali M; Basso A; Piacenza F; Postacchini D; Galeazzi R; Fattoretti P; Nisi L; Fabbietti P; Papa R; Malavolta M
J Trace Elem Med Biol; 2019 Sep; 55():58-63. PubMed ID: 31345366
[TBL] [Abstract][Full Text] [Related]
22. Prevalence and predictors of anticholinergic medication use in elderly nursing home residents with dementia: analysis of data from the 2004 National Nursing Home Survey.
Chatterjee S; Mehta S; Sherer JT; Aparasu RR
Drugs Aging; 2010 Dec; 27(12):987-97. PubMed ID: 21087068
[TBL] [Abstract][Full Text] [Related]
23. [Risk/benefit assessment in the treatment of Alzheimer's disease. Drug interactions].
Hernández-Arroyo MJ; Díaz-Madero A
Rev Esp Geriatr Gerontol; 2016; 51(4):191-5. PubMed ID: 26775172
[TBL] [Abstract][Full Text] [Related]
24. Threshold for a Reduction in Anticholinergic Burden to Decrease Behavioral and Psychological Symptoms of Dementia.
Jaïdi Y; Guilloteau A; Nonnonhou V; Bertholon LA; Badr S; Morrone I; Novella JL; Mahmoudi R
J Am Med Dir Assoc; 2019 Feb; 20(2):159-164.e3. PubMed ID: 30503588
[TBL] [Abstract][Full Text] [Related]
25. Association between using medications with anticholinergic properties and short-term cognitive decline among older men: A retrospective cohort study in Taiwan.
Wu YH; Wang CJ; Hung CH; Chen LY; Lin MH; Wang PN; Chen LK
Geriatr Gerontol Int; 2017 Apr; 17 Suppl 1():57-64. PubMed ID: 28436193
[TBL] [Abstract][Full Text] [Related]
26. Drugs with anticholinergic properties, cognitive decline, and dementia in an elderly general population: the 3-city study.
Carrière I; Fourrier-Reglat A; Dartigues JF; Rouaud O; Pasquier F; Ritchie K; Ancelin ML
Arch Intern Med; 2009 Jul; 169(14):1317-24. PubMed ID: 19636034
[TBL] [Abstract][Full Text] [Related]
27. Anticholinergic burden before and after hospitalization in older adults with dementia: Increase due to antipsychotic medications.
Reinold J; Palese F; Romanese F; Logroscino G; Riedel O; Pisa FE
Int J Geriatr Psychiatry; 2019 Jun; 34(6):868-880. PubMed ID: 30761624
[TBL] [Abstract][Full Text] [Related]
28. Acetylcholinesterase inhibitors for treating dementia symptoms - a safety evaluation.
Mohammad D; Chan P; Bradley J; Lanctôt K; Herrmann N
Expert Opin Drug Saf; 2017 Sep; 16(9):1009-1019. PubMed ID: 28678552
[TBL] [Abstract][Full Text] [Related]
29. [Anticholinergic scales: Use in psychiatry and update of the anticholinergic impregnation scale].
Javelot H; Meyer G; Becker G; Post G; Runge V; Pospieszynski P; Schneiderlin T; Armand-Branger S; Michel B; Weiner L; Faria CGF; Drapier D; Fakra E; Fossati P; Haffen E; Yrondi A; Hingray C
Encephale; 2022 Jun; 48(3):313-324. PubMed ID: 34876278
[TBL] [Abstract][Full Text] [Related]
30. Anticholinergic drug burden according to the anticholinergic drug scale and the German anticholinergic burden and their impact on cognitive function in multimorbid elderly German people: a multicentre observational study.
Krüger C; Schäfer I; van den Bussche H; Bickel H; Fuchs A; Gensichen J; König HH; Maier W; Mergenthal K; Riedel-Heller SG; Schön G; Weyerer S; Wiese B; von Renteln-Kruse W; Langebrake C; Scherer M
BMJ Open; 2021 Mar; 11(3):e044230. PubMed ID: 33757948
[TBL] [Abstract][Full Text] [Related]
31. Benefits of Treatment with Ginkgo Biloba Extract EGb 761 Alone or Combined with Acetylcholinesterase Inhibitors in Vascular Dementia.
García-Alberca JM; Mendoza S; Gris E
Clin Drug Investig; 2022 May; 42(5):391-402. PubMed ID: 35349093
[TBL] [Abstract][Full Text] [Related]
32. Relation between anticholinergic burden and cognitive impairment: Results from the Monzino 80-plus population-based study.
Pasina L; Lucca U; Tettamanti M
Pharmacoepidemiol Drug Saf; 2020 Dec; 29(12):1696-1702. PubMed ID: 33098318
[TBL] [Abstract][Full Text] [Related]
33. Do Acetylcholinesterase Inhibitors Prevent or Delay Psychotropic Prescribing in People With Dementia? Analyses of the Swedish Dementia Registry.
Tan ECK; Johnell K; Bell JS; Garcia-Ptacek S; Fastbom J; Nordström P; Eriksdotter M
Am J Geriatr Psychiatry; 2020 Jan; 28(1):108-117. PubMed ID: 31331724
[TBL] [Abstract][Full Text] [Related]
34. Delirium is not associated with anticholinergic burden or polypharmacy in older patients on admission to an acute hospital: an observational case control study.
Moorey HC; Zaidman S; Jackson TA
BMC Geriatr; 2016 Sep; 16(1):162. PubMed ID: 27655289
[TBL] [Abstract][Full Text] [Related]
35. Factors associated with response to acetylcholinesterase inhibition in dementia: a cohort study from a secondary mental health care case register in london.
Perera G; Khondoker M; Broadbent M; Breen G; Stewart R
PLoS One; 2014; 9(11):e109484. PubMed ID: 25411838
[TBL] [Abstract][Full Text] [Related]
36. Prescription patterns of anticholinergic agents and their associated factors in Korean elderly patients with dementia.
Lee EK; Lee YJ
Int J Clin Pharm; 2013 Oct; 35(5):711-8. PubMed ID: 23708883
[TBL] [Abstract][Full Text] [Related]
37. Trends in the Prescription and Long-Term Utilization of Antidementia Drugs Among Patients with Alzheimer's Disease in Spain: A Cohort Study Using the Registry of Dementias of Girona.
Calvó-Perxas L; Turró-Garriga O; Vilalta-Franch J; Lozano-Gallego M; de Eugenio R; Márquez F; Carmona O; Gich J; Manzano A; Viñas M; Roig AM; Garre-Olmo J;
Drugs Aging; 2017 Apr; 34(4):303-310. PubMed ID: 28258538
[TBL] [Abstract][Full Text] [Related]
38. Anticholinergic medications in patients admitted with cognitive impairment or falls (AMiCI). The impact of hospital admission on anticholinergic cognitive medication burden. Results of a multicentre observational study.
Weichert I; Romero-Ortuno R; Tolonen J; Soe T; Lebus C; Choudhury S; Nadarajah CV; Nanayakkara P; Orrù M; Di Somma S;
J Clin Pharm Ther; 2018 Oct; 43(5):682-694. PubMed ID: 29729025
[TBL] [Abstract][Full Text] [Related]
39. Association between antidementia medication use and mortality in people diagnosed with dementia with Lewy bodies in the UK: A retrospective cohort study.
Chen S; Price AC; Cardinal RN; Moylett S; Kershenbaum AD; Fitzgerald J; Mueller C; Stewart R; O'Brien JT
PLoS Med; 2022 Dec; 19(12):e1004124. PubMed ID: 36472984
[TBL] [Abstract][Full Text] [Related]
40. A Systematic Review and Meta-Analysis of the Effectiveness of Acetylcholinesterase Inhibitors and Memantine in Treating the Cognitive Symptoms of Dementia.
Knight R; Khondoker M; Magill N; Stewart R; Landau S
Dement Geriatr Cogn Disord; 2018; 45(3-4):131-151. PubMed ID: 29734182
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
